Perspective Therapeutics (CATX) EBITDA Margin (QoQ) (2010 - 2023)
Perspective Therapeutics (CATX) EBITDA Margin (QoQ) (2010 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 68,441.00 |
| Sep 30, 2023 | 20,404.00 |
| Jun 30, 2023 | -11,688.00 |
| Sep 30, 2022 | -16,101.00 |
| Jun 30, 2022 | -3,679.00 |
| Mar 31, 2022 | 1,078.00 |
| Dec 31, 2021 | 3,063.00 |
| Sep 30, 2021 | -13,836.00 |
| Jun 30, 2021 | 7,913.00 |
| Mar 31, 2021 | 755.00 |
| Dec 31, 2020 | -706.00 |
| Sep 30, 2020 | 2,222.00 |
| Jun 30, 2020 | -3,314.00 |
| Mar 31, 2020 | 2,191.00 |
| Dec 31, 2019 | -482.00 |
| Sep 30, 2019 | 2,335.00 |
| Jun 30, 2019 | 99.00 |
| Mar 31, 2019 | 1,461.00 |
| Dec 31, 2018 | 2,213.00 |
| Sep 30, 2018 | 5,066.00 |